Search Results - "ESPINER, E"

Refine Results
  1. 1

    Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population by Prickett, T. C. R., Olney, R. C., Cameron, V. A., Ellis, M. J., Richards, A. M., Espiner, E. A.

    Published in Clinical endocrinology (Oxford) (01-05-2013)
    “…Summary Context In contrast to the cardiac hormones, atrial natriuretic peptide (ANP) and B‐type natriuretic peptide (BNP), variations in plasma concentrations…”
    Get full text
    Journal Article
  2. 2

    Postnatal effects of intrauterine treatment of the growth‐restricted ovine fetus with intra‐amniotic insulin‐like growth factor‐1 by Spiroski, A. M., Oliver, M. H., Jaquiery, A. L., Prickett, T. C. R., Espiner, E. A., Harding, J. E., Bloomfield, F. H.

    Published in The Journal of physiology (01-12-2018)
    “…Key points Fetal growth restriction increases the risk of fetal and neonatal mortality and morbidity, and contributes to increased risk of chronic disease…”
    Get full text
    Journal Article
  3. 3

    Effects of pre‐eclampsia and fetal growth restriction on C‐type natriuretic peptide by Espiner, EA, Prickett, TCR, Taylor, RS, Reid, RA, McCowan, LM

    “…Objective To determine changes in plasma C–type natriuretic peptide (CNP), a paracrine product of the vascular endothelium, in pregnancies with vascular…”
    Get full text
    Journal Article
  4. 4

    Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations by Troughton, Richard W, Frampton, Christopher M, Yandle, Timothy G, Espine, Eric A, Nicholls, M Gary, Richards, A Mark

    Published in The Lancet (British edition) (01-04-2000)
    “…There is currently no objective practical guide to intensity of drug treatment for individuals with heart failure. We hypothesised that pharmacotherapy guided…”
    Get full text
    Journal Article
  5. 5

    Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment by Hunt, P. J., Richards, A. M., Nicholls, M. G., Yandle, T. G., Doughty, R. N., Espiner, E. A.

    Published in Clinical endocrinology (Oxford) (01-09-1997)
    “…OBJECTIVE Human brain natriuretic peptide‐32 (BNP) (i.e. proBNP(77–108)), the mature form of BNP and secreted predominantly by the cardiac ventricle, is formed…”
    Get full text
    Journal Article
  6. 6

    C-type natriuretic peptide in Parkinson’s disease: reduced secretion and response to deprenyl by Espiner, E. A., Dalrymple-Alford, J. C., Prickett, T. C. R., Alamri, Y., Anderson, T. J.

    Published in Journal of Neural Transmission (01-04-2014)
    “…C-type natriuretic peptide (CNP) is a neurotrophic factor widely expressed in the central nervous system including the basal ganglia, limbic system and…”
    Get full text
    Journal Article
  7. 7

    Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats by Prickett, T C R, Bothwell, J C, Yandle, T G, Richards, A M, Espiner, E A

    Published in Journal of endocrinology (01-02-2012)
    “…Studies from genetic modification and spontaneous mutations show that C-type natriuretic peptide (CNP) signalling plays an essential part in postnatal…”
    Get full text
    Journal Article
  8. 8

    Predicting Surgically Remedial Primary Aldosteronism: Role of Adrenal Scanning, Posture Testing, and Adrenal Vein Sampling by Espiner, E. A., Ross, D. G., Yandle, T. G., Richards, A. M., Hunt, P. J.

    “…Distinguishing surgically remedial forms from other causes of primary aldosteronism (PA) may be difficult, and it is made more challenging by the earlier…”
    Get full text
    Journal Article
  9. 9

    Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction by Richards, A M, Nicholls, M G, Yandle, T G, Ikram, H, Espiner, E A, Turner, J G, Buttimore, R C, Lainchbury, J G, Elliott, J M, Frampton, C, Crozier, I G, Smyth, D W

    Published in Heart (British Cardiac Society) (01-02-1999)
    “…Objective To determine the relations of plasma levels of brain natriuretic peptide (BNP), atrial natriuretic factor (ANF), N-terminal ANF (N-ANF), cyclic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction by RICHARDS, A. M, DOUGHTY, R, NICHOLLS, M. G, MACMAHON, S, IKRAM, H, SHARPE, N, ESPINER, E. A, FRAMPTON, C, YANDLE, T. G

    Published in Circulation (New York, N.Y.) (16-02-1999)
    “…Background —Plasma neurohormones were analyzed for prediction of adverse outcomes and response to treatment in 415 patients with ischemic left ventricular…”
    Get full text
    Journal Article
  12. 12

    Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease by Reh, C. S., Olney, R. C., Azen, C., Prickett, T. C., Espiner, E. A., Geffner, M. E.

    Published in Clinical endocrinology (Oxford) (01-02-2012)
    “…Summary Objective  C‐type natriuretic peptide (CNP) and thyroid hormone (TH) are essential for normal skeletal growth. Plasma CNP peptides correlate with…”
    Get full text
    Journal Article
  13. 13

    The trophoblast binucleate cell is the source of maternal circulating C-type natriuretic peptide during ovine pregnancy by McNeill, B.A, Barrell, G.K, Wooding, F.B.P, Prickett, T.C.R, Espiner, E.A

    Published in Placenta (Eastbourne) (01-09-2011)
    “…Abstract Maternal plasma concentrations of C-type natriuretic peptide (CNP) and a co-secreted bioinactive amino-terminal fragment (NTproCNP) are elevated…”
    Get full text
    Journal Article
  14. 14

    Plasma brain natriuretic peptide in assessment of acute dyspnoea by Davis, M, Espiner, E, Richards, G, Billings, J, Town, I, Neill, A, Drennan, C, Richards, M, Turner, J, Yandle, T

    Published in The Lancet (British edition) (19-02-1994)
    “…Recognition of heart failure (HF) may be difficult in patients presenting with acute dyspnoea, particularly in the presence of chronic airways obstruction…”
    Get more information
    Journal Article
  15. 15

    Identification of Amino-Terminal Pro-C-Type Natriuretic Peptide in Human Plasma by Prickett, T.C.R., Yandle, T.G., Nicholls, M.G., Espiner, E.A., Richards, A.M.

    “…We report the first identification of a circulating peptide from the amino-terminal end of proCNP. A specific radioimmunoassay was established based on…”
    Get full text
    Journal Article
  16. 16

    Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase by Smith, MW, Espiner, EA, Yandle, TG, Charles, CJ, Richards, AM

    Published in Journal of endocrinology (01-11-2000)
    “…Metabolism of natriuretic peptides is regulated by two degradative pathways: uptake by the clearance receptor (natriuretic peptide receptor C--NPR-C) and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    B-Type natriuretic peptides and ejection fraction for prognosis after myocardial infarction by RICHARDS, A. Mark, NICHOLLS, M. Gary, ESPINER, Eric A, LAINCHBURY, John G, TROUGHTON, Richard W, ELLIOTT, John, FRAMPTON, Christopher, TURNER, John, CROZIER, Ian G, YANDLE, Timothy G

    Published in Circulation (New York, N.Y.) (10-06-2003)
    “…A recent landmark report has demonstrated that plasma B-type natriuretic peptide (BNP) measured in acute coronary syndromes independently predicts mortality,…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man by Holmes, S J, Espiner, E A, Richards, A M, Yandle, T G, Frampton, C

    “…Brain Natriuretic Peptide (BNP) is a recently identified hormone which is secreted by the human heart and circulates in plasma. To determine the effects of…”
    Get more information
    Journal Article